LENGAUER, HANNES,PICHLER, ARTHUR,MARGREITER, RENATE,GELBRICH, THOMAS
申请号：
CA3074529
公开号：
CA3074529A1
申请日:
2018.07.11
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
The present invention relates to a co-crystal of roxadustat with L-proline and to a process for its preparation. Furthermore, the invention relates to a pharmaceutical composition comprising said roxadustat L-proline co-crystal, at least one pharmaceutically acceptable excipient and optionally at least one photostabilizing agent. The pharmaceutical composition of the present invention can be used as a medicament, in particular for the treatment and/or prevention of anemia in patients with end-stage renal disease (ESRD) and/or chronic kidney disease (CKD).
